Summary

The global carrier screening market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments in research and developments activities by the government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.
Rising Prevalence of Genetic Diseases
The rising incidences of genetic disorders and fetal chromosomal anomalies due to mutation in genes or chromosomes are bolstering the growth of the market globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia occur due to inheritable genetic conditions present in parents, which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.
Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders
In recent years, people have become more aware of genetic disorders, which enables them to plan and take better care of their babies. The growing inclination among urban parents to delay childbearing and the higher average age of mothers lead to pregnancy complications, which is a contributing factor to facilitating the growth of the market. Early detection helps couples to know the risk of having a child with genetic diseases or disorders in an early stage of pregnancy. Thus, the rising focus on early detection and prevention of complex genetic disorders is fueling the growth of the market globally. Various initiatives are taken by government and non-government organizations for early carrier screening. For instance, in 2018, “Step One Newborn Screening” was introduced by the Dubai health authority.
Technological Advancements fuel the Market Growth.
The rise in the adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of an NGS-based test kit, which is a type of carrier screening approach in single solution that assists in scanning genetic disorders, including gene expression.
Market Segmentation
The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down’s syndrome, thalassemia, tay sachs disease, Huntington’s disease, sickle cell anemia, and others. Based on end-user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.
Market Players
Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.
Report Scope:
In this report, global carrier screening market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
• Carrier Screening Market, By Type:
o Expanded Carrier Screening
o Targeted Cancer Screening
• Carrier Screening Market, By Screening Type:
o Prenatal Carrier Testing
o Preconception Carrier Screening
• Carrier Screening Market, By Technology:
o Next-Generation Sequencing
o Polymerase Chain Reaction
o Microarrays
o Others
• Carrier Screening Market, By Indication:
o Cystic Fibrosis
o Down’s Syndrome
o Thalassemia
o Tay-Sachs Disease
o Huntington’s Disease
o Sickle Cell Anemia
o Others
• Carrier Screening Market, By End User:
o Hospitals & Clinics
o Reference Laboratories
o Others
• Carrier Screening Market, By Region:
o North America
 United States
 Canada
 Mexico
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o Europe & CIS
 Germany
 France
 United Kingdom
 Spain
 Italy
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Turkey
 Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Carrier Screening Market
5. Voice of Customer
6. Global Carrier Screening Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)
6.2.2. By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)
6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)
6.2.4. By Indication (Cystic Fibrosis, Down’s Syndrome, Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia, Others)
6.2.5. By End User (Hospitals & Clinics, Reference Laboratories, Others)
6.2.6. By Region
6.2.7. By Company (2021)
6.3. Market Map
7. North America Carrier Screening Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Screening Type
7.2.3. By Technology
7.2.4. By Indication
7.2.5. By End User
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Carrier Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Screening Type
7.3.1.2.3. By Technology
7.3.1.2.4. By Indication
7.3.1.2.5. By End User
7.3.2. Canada Carrier Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Screening Type
7.3.2.2.3. By Technology
7.3.2.2.4. By Indication
7.3.2.2.5. By End User
7.3.3. Mexico Carrier Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Screening Type
7.3.3.2.3. By Technology
7.3.3.2.4. By Indication
7.3.3.2.5. By End User
8. Europe Carrier Screening Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Screening Type
8.2.3. By Technology
8.2.4. By Indication
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Carrier Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Screening Type
8.3.1.2.3. By Technology
8.3.1.2.4. By Indication
8.3.1.2.5. By End User
8.3.2. Germany Carrier Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Screening Type
8.3.2.2.3. By Technology
8.3.2.2.4. By Indication
8.3.2.2.5. By End User
8.3.3. United Kingdom Carrier Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Screening Type
8.3.3.2.3. By Technology
8.3.3.2.4. By Indication
8.3.3.2.5. By End User
8.3.4. Italy Carrier Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Screening Type
8.3.4.2.3. By Technology
8.3.4.2.4. By Indication
8.3.4.2.5. By End User
8.3.5. Spain Carrier Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Screening Type
8.3.5.2.3. By Technology
8.3.5.2.4. By Indication
8.3.5.2.5. By End User
9. Asia-Pacific Carrier Screening Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Screening Type
9.2.3. By Technology
9.2.4. By Indication
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Carrier Screening Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Screening Type
9.3.1.2.3. By Technology
9.3.1.2.4. By Indication
9.3.1.2.5. By End User
9.3.2. India Carrier Screening Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Screening Type
9.3.2.2.3. By Technology
9.3.2.2.4. By Indication
9.3.2.2.5. By End User
9.3.3. Japan Carrier Screening Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Screening Type
9.3.3.2.3. By Technology
9.3.3.2.4. By Indication
9.3.3.2.5. By End User
9.3.4. South Korea Carrier Screening Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Screening Type
9.3.4.2.3. By Technology
9.3.4.2.4. By Indication
9.3.4.2.5. By End User
9.3.5. Australia Carrier Screening Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Screening Type
9.3.5.2.3. By Technology
9.3.5.2.4. By Indication
9.3.5.2.5. By End User
10. South America Carrier Screening Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Screening Type
10.2.3. By Technology
10.2.4. By Indication
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Carrier Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Screening Type
10.3.1.2.3. By Technology
10.3.1.2.4. By Indication
10.3.1.2.5. By End User
10.3.2. Argentina Carrier Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Screening Type
10.3.2.2.3. By Technology
10.3.2.2.4. By Indication
10.3.2.2.5. By End User
10.3.3. Colombia Carrier Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Screening Type
10.3.3.2.3. By Technology
10.3.3.2.4. By Indication
10.3.3.2.5. By End User
11. Middle East and Africa Carrier Screening Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Screening Type
11.2.3. By Technology
11.2.4. By Indication
11.2.5. By End User
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Carrier Screening Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Screening Type
11.3.1.2.3. By Technology
11.3.1.2.4. By Indication
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Carrier Screening Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Screening Type
11.3.2.2.3. By Technology
11.3.2.2.4. By Indication
11.3.2.2.5. By End User
11.3.3. UAE Carrier Screening Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Screening Type
11.3.3.2.3. By Technology
11.3.3.2.4. By Indication
11.3.3.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape (Inclusive of SWOT Analysis)
14.1. Eurofins Scientific, Inc.
14.2. Fulgent Genetics, Inc.
14.3. CENTOGENE N.V.
14.4. Invitae Corporation
14.5. Illumina, Inc.
14.6. Gene by Gene, Ltd.
14.7. Laboratory Corporation of America Holdings
14.8. Natera, Inc.
14.9. Myriad Genetics, Inc.
14.10. Quest Diagnostics, Inc.
15. Strategic Recommendations